Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/882291/000168316818000270/aethlon_10q-123117.htm
SEC Filings
AEMD Annual Reports
AEMD Quarterly Reports
10-Q Quarterly Report November 2023
10-Q Quarterly Report August 2023
10-Q Quarterly Report February 2023
10-Q Quarterly Report November 2022
10-Q Quarterly Report August 2022
10-Q Quarterly Report February 2022
10-Q Quarterly Report November 2021
10-Q Quarterly Report August 2021
10-Q Quarterly Report February 2021
10-Q Quarterly Report October 2020
10-Q Quarterly Report November 2023
10-Q Quarterly Report August 2023
10-Q Quarterly Report February 2023
10-Q Quarterly Report November 2022
10-Q Quarterly Report August 2022
10-Q Quarterly Report February 2022
10-Q Quarterly Report November 2021
10-Q Quarterly Report August 2021
10-Q Quarterly Report February 2021
10-Q Quarterly Report October 2020
AEMD Corporate News
Event for Officers
Financial Exhibit November 2023
Earnings Release
Financial Exhibit November 2023
Event for Officers November 2023
Financial Exhibit
Other Events October 2023
Vote of Security Holders September 2023
Earnings Release
Financial Exhibit August 2023
Event for Officers July 2023
Earnings Release
Financial Exhibit June 2023
Other Events April 2023
Earnings Release
Financial Exhibit February 2023
Event for Officers
Financial Exhibit
Financial Exhibit
November 2023
Earnings Release
Financial Exhibit
Financial Exhibit
November 2023
Event for Officers
November 2023
Financial Exhibit
Other Events
Other Events
October 2023
Vote of Security Holders
September 2023
Earnings Release
Financial Exhibit
Financial Exhibit
August 2023
Event for Officers
July 2023
Earnings Release
Financial Exhibit
Financial Exhibit
June 2023
Other Events
April 2023
Earnings Release
Financial Exhibit
Financial Exhibit
February 2023
Last10K.com | 10-Q Quarterly Report Thu Feb 01 2018
Document and Entity Information - shares | 9 Months Ended | |
|---|---|---|
Dec. 31, 2017 | Jan. 31, 2018 | |
| Document And Entity Information | ||
| Entity Registrant Name | AETHLON MEDICAL INC | |
| Entity Central Index Key | 0000882291 | |
| Document Type | 10-Q | |
| Document Period End Date | Dec. 31, 2017 | |
| Amendment Flag | false | |
| Current Fiscal Year End Date | --03-31 | |
| Is Entity a Well-known Seasoned Issuer? | No | |
| Is Entity a Voluntary Filer? | No | |
| Is Entity's Reporting Status Current? | Yes | |
| Entity Filer Category | Smaller Reporting Company | |
| Entity Common Stock, Shares Outstanding | 16,580,326 | |
| Document Fiscal Period Focus | Q3 | |
| Document Fiscal Year Focus | 2018 |
View differences made from one quarter to another to evaluate Aethlon Medical Inc's financial trajectory
Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Aethlon Medical Inc.
Assess how Aethlon Medical Inc's management team is paid from their Annual Proxy
Aethlon Medical Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:
- Voting Procedures
- Board Members
- Executive Team
- Salaries, Bonuses, Perks
- Peers / Competitors
SEC Filing Tools
Financial Statements, Disclosures and Schedules
Inside this 10-Q Quarterly Report
Document And Entity Information
Condensed Consolidated Balance Sheets (parenthetical)
Condensed Consolidated Balance Sheets (unaudited)
Condensed Consolidated Statements Of Cash Flows (unaudited)
Condensed Consolidated Statements Of Operations (unaudited)
1. Nature Of Business And Basis Of Presentation
1. Nature Of Business And Basis Of Presentation (policies)
10. Warrants
10. Warrants (details - Assumptions)
10. Warrants (details - Warrant Activity)
10. Warrants (details Narrative)
10. Warrants (tables)
11. Darpa Contract And Related Revenue Recognition (details Narrative)
11. Government Contracts And Related Revenue Recognition
12. Segments
12. Segments (details)
12. Segments (tables)
13. Commitments And Contingencies
13. Commitments And Contingencies (details Narrative)
14. Subsequent Events
2. Loss Per Common Share
2. Loss Per Common Share (details Narrative)
3. Research And Development Expenses
3. Research And Development Expenses (details)
3. Research And Development Expenses (tables)
4. Future Accounting Pronouncements
5. Convertible Notes Payable (details - Convertible Note Activity)
5. Convertible Notes Payable (details - Convertible Notes Payable)
5. Convertible Notes Payable (details Narrative)
5. Convertible Notes Payable (tables)
5. Convertible Notes Payable, Net
6. Equity Transactions
6. Equity Transactions (details Narrative)
7. Related Party Transactions
7. Related Party Transactions (details Narrative)
8. Other Current Liabilities
8. Other Current Liabilities (details)
8. Other Current Liabilities (tables)
9. Stock Compensation
9. Stock Compensation (details - Assumptions)
9. Stock Compensation (details - Option Activity)
9. Stock Compensation (details - Options Vested And Expected To Vest)
9. Stock Compensation (details - Rsu's Outstanding)
9. Stock Compensation (details - Share Based Compensation)
9. Stock Compensation (details Narrative)
9. Stock Compensation (tables)
Material Contracts, Statements, Certifications & more
Aethlon Medical Inc provided additional information to their SEC Filing as exhibits
Ticker: AEMD
CIK: 882291
Form Type: 10-Q Quarterly Report
Accession Number: 0001683168-18-000270
Submitted to the SEC: Thu Feb 01 2018 5:21:09 PM EST
Accepted by the SEC: Thu Feb 01 2018
Period: Sunday, December 31, 2017
Industry: Laboratory Analytical Instruments
External Resources:
Stock Quote
Social Media
SEC.gov
Bookmark the Permalink: https://last10k.com/sec-filings/aemd/0001683168-18-000270.htm
SEC Filing Exhibit
PDF Download
Loading SEC Filing Exhibit...
Excel DownloadLoading SEC Filing Financial Summary...